Dataset Information


The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

ABSTRACT: Cancer remains a leading causes of death worldwide and an elevated systemic inflammatory response (SIR) is associated with reduced survival in patients with operable cancer. This review aims to examine the evidence for the role of systemic inflammation based prognostic scores in patients with operable cancers. A wide-ranging literature review using targeted medical subject headings for human studies in English was carried out in the MEDLINE, EMBASE, and CDSR databases until the end of 2016. The SIR has independent prognostic value, across tumour types and geographical locations. In particular neutrophil lymphocyte ratio (NLR) (n?=?158), platelet lymphocyte ratio (PLR) (n?=?68), lymphocyte monocyte ratio (LMR) (n?=?21) and Glasgow Prognostic Score/ modified Glasgow Prognostic Score (GPS/mGPS) (n?=?60) were consistently validated. On meta-analysis there was a significant relationship between elevated NLR and overall survival (OS) (p?


PROVIDER: S-EPMC5711862 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5300029 | BioStudies
1000-01-01 | S-EPMC5386740 | BioStudies
2020-01-01 | S-EPMC7578034 | BioStudies
2020-01-01 | S-EPMC7046751 | BioStudies
2020-01-01 | S-EPMC7422564 | BioStudies
2017-01-01 | S-EPMC5601158 | BioStudies
2017-01-01 | S-EPMC5538703 | BioStudies
1000-01-01 | S-EPMC5681757 | BioStudies
2016-01-01 | S-EPMC4817406 | BioStudies
2020-01-01 | S-EPMC7527435 | BioStudies